scroll to top
0

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "suhail malik"

Filter
1 - 2 of 2 results for
 "suhail malik"
Results per page:
Sort By:
Your filters
  • Filter by:
  • Source Type: Magazines
  • Content Provider: Supplemental Index
  • Reset filters

    • Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

    Publication Type: Periodical

    Source(s): The Lancet; July-August 2022, Vol. 400 Issue: 10349 p359-368, 10p

    Abstract: We aimed to evaluate the use of baricitinib, a Janus kinase (JAK) 1–2 inhibitor, for the treatment of patients admitted to hospital with COVID-19.

    Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    Publication Type: Periodical

    Source(s): The Lancet Diabetes & Endocrinology; August 2019, Vol. 7 Issue: 8 p618-628, 11p

    Abstract: After acute coronary syndrome, diabetes conveys an excess risk of ischaemic cardiovascular events. A reduction in mean LDL cholesterol to 1·4–1·8 mmol/L with ezetimibe or statins reduces cardiovascular events in patients with an acute coronary syndrome...

    sponsored